FGF2 and glioblastoma: In this sense, the levels of VEGF and fibroblast growth factor 2 (FGF2) were shown to be significantly higher in patients with glioblastoma and associated with shorter overall survival rate, demonstrating the usefulness of these proteins as potential diagnostic and prognostic biomarkers [107].